Interactions between NO and cAMP in the regulation of vascular tone: Editorial

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 5, 2001, Pages 729-730

  Lamping, Kathryn ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CAMP; CGMP; Coronary circulation; Nitric oxide; Nitric oxide synthase

Indexed keywords

ACETYLCHOLINE; BRADYKININ; CYCLIC AMP; FORSKOLIN; ISOPRENALINE; NITRIC OXIDE;

BLOOD VESSEL TONE; EDITORIAL; ENZYME INHIBITION; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE;

EID: 0035026199     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.5.729     Document Type: Editorial

References (34)

1. Steinhorn RH, Morin FC III, Van Wylen DGL, Gugino SF, Giese EC, Russell JA. Endothelium-dependent relaxations to adenosine in juvenile rabbit pulmonary arteries and veins. Am J Physiol. 1994;266:H2001-H2006.
2. Vials A, Burnstock G. A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide. Br J Pharmacol. 1993;109: 424-429.
3. Zanninger J, Bassenge E. Coronary vasodilation to acetylcholine, adenosine, and bradykinin in dogs: effects of inhibition of NO-synthesis and captopril. Eur Heart J. 1993;14(suppl I):I-64 -I-65.
4. Rubanyi G, Vanhoutte PM. Endothelium removal decreases relaxations of canine coronary arteries caused by b-adrenergic agonists and adenosine. J Cardiovasc Pharmacol. 1985;7:139-144.
5. Grace GC, Macdonald PS, Dusting GJ. Cyclic nucleotide interactions involved in endothelium-dependent dilation in rat aortic rings. Eur J Pharmacol. 1988;148:17-24.
6. Ito M, Yamamoto I, Naruse A, Suzuki Y, Sataake N, Shibata S. Impaired relaxing response to isoprenaline in isolated thoracic aorta of nephrotic rats: decrease in release of EDRF from endothelial cells. J Cardiovasc Pharmacol. 1997;29:232-239.
7. Shimokawa H, Flavahan NA, Lorenz RR, Vanhoutte PM. Prostacyclin releases endothelium-derived relaxant factor and potentiates its action in coronary arteries of the pig. Br J Pharmacol. 1988;95:1197-1203.
8. Gardiner SM, Kemp PA, Bennett T. Effect of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 59-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br J Pharmacol. 1991;103:1725-1732.
9. Gray DW, Marshall I. Novel signal transduction pathway mediating endothelium-dependent b-adrenoceptor vasorelaxation in rat thoracic aorta. Br J Pharmacol. 1992;107:684-690.
10. Wang YX, Poon KS, Randall DJ, Pang CCY. Endothelium-derived nitric oxide partially mediates salbutamol-induced vasodilations. Br J Pharmacol. 1993;250:335-340.
11. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO III, Panza JA. Decreased vasodilation response to isoproterenol during nitric oxide inhibition in humans. Hypertension. 1997;30:918-921.
12. Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by b-adrenergic agonists in human forearm. Circulation. 1997;95:2293-2297.
13. Rebich S, Devine JO, Armstead WM. Role of nitric oxide and cAMP in b-adrenoceptor-induced pial artery vasodilation. Am J Physiol. 1995;268: H1071-H1076.
14. Iadecola C. Does nitric oxide mediate the increases in cerebral blood flow elicited by hypercapnia. Proc Natl Acad Sci U S A. 1992;89:3913-3916.
15. Iadecola C, Zhang F. Permissive and obligatory roles of NO in cerebrovascular responses to hypercapnia and acetylcholine. Am J Physiol. 1996; 271:R990-R991.
16. Ichihara A, Imig JD, Inscho EW, Navar LG. Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar tone: interactions with neuronal NOS. Am J Physiol. 1998;275:F605-F612.
17. Puybasset L, Bea ML, Ghaleh B, Giudicelli JF, Berdeaux A. Coronary and systemic hemodynamic effects of sustained inhibition of nitric oxide synthesis in conscious dogs: evidence for cross talk between nitric oxide and cyclooxygenase in coronary vessels. Circ Res. 1996;79:343-357.
18. Salazar FJ, Llinas MT, Gonzalez JD, Quesada T, Pinilla JM. Role of prostaglandins and nitric oxide in mediating renal response to volume expansion. Am J Physiol. 1995;268:R1442-R1448.
19. Duffy SJ, Castle SF, Harper RW, Meredith IT. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation. Circulation. 1999;100: 1951-1957.
20. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol. 1990;30:535-560.
21. Smith WL, Marnett LJ. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta. 1991;1083:1-17.
22. Siess W, Lapetina EG. Functional relationship between cAMP-dependent protein phosphorylation and platelet inhibition. Biochem J. 1990;271:815-819.
23. Maurice DH, Haslam RJ. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol. 1990; 37:671-681.
24. de Wit C, von Bismark P, Pohl U. Synergistic action of vasodilators that increase cGMP and cAMP in the hamster cremaster microcirculation. Circ Res. 1994;28:1513-1518.
25. Walter U, Nolte C, Geiger P, Schanzenbacher P, Kocksiek K. Inhibition of platelet function by cyclic nucleotides and cyclic nucleotide-dependent protein kinases. In: Hermann AG, ed. Antithrombotics. Dordrecht, Germany: Kluwer Academic Publishers; 1991:121-138.
26. Walter U. Physiological role of cGMP, and cGMP-dependent protin kinase in the cardiovascualr system. Rev Physiol Biochem Pharmacol. 1989;113: 41-88.
27. Zhang X, Hintze TH. cAMP signal transduction cascade, a novel pathway for the regulation of endothelial nitric oxide production in coronary blood vessels. Arterioscler Thromb Vasc Biol 2001;21:797-803.
28. Lamping KG, Nuno DW, Shesely EG, Maeda N, Faraci FM. Vasodilator mechanisms in the coronary circulation of nitric oxide synthase-deficient mice. Am J Physiol. 2000;279:H1906-H1912.
29. Godecke A, Decking UKM, Ding Z, Hirchenhain J, Bidmon HJ, Godecke S, Schrader J. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res. 1998;82:186-194.
30. Meng W, Ayata C, Waeber C, Huang PL, Moskowitz MA. Neuronal NOScGMP-dependent ACh-induced relaxation in pial arterioles of endothelial NOS knockout mice. Am J Physiol. 1998;274:H411-H415.
31. Sun D, Huang A, Smith CJ, Stackpole CJ, Connetta JA, Shesely EG, Koller A, Kaley G. Enhanced release of prostaglandins to flow-induced arteriolar dilation in eNOS knockout mice. Circ Res. 1999;85:288-293.
32. Huang A, Sun D, Smith CJ, Connetta JA, Shesely EG, Koller A, Kaley G. In eNOS knockout mice skeletal muscle arteriolar dilation to acetylcholine is mediated by EDHF. Am J Physiol. 2000;278:H762-H768.
33. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;337:239-242.
34. Faraci FM, Sigmund CD, Shesely EG, Maeda N, Heistad DD. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Physiol. 1998;274:H564-H570.